Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-018-0115-6
PubMed Identifier: 30013198
Publication URI: http://europepmc.org/abstract/MED/30013198
Type: Journal Article/Review
Volume: 24
Parent Publication: Nature medicine
Issue: 8
ISSN: 1078-8956